| New Jersey | July 10 2026 HEC Pharm has formally entered into an agreement with Accutar, a leading global AI-enabled drug discovery company, to form a new company (“NewCo”) and jointly develop an innovative drug pipeline based on Regulated Induced Proximity Targeting Chimera (RIPTAC) technology. The pipeline’s lead indication will be metastatic castration-resistant prostate cancer […] |
Discovery
Learnings
- auto_storiesStories
- categoryAreas
- helpFAQ
- forumConversations
- descriptionPapers
- mailNewsletters
- video_libraryVideos
- timelineTimeline
Guidance
- codeTechnology of APIs
- business_centerBusiness of APIs
- campaignEvangelism of APIs
- gavelGovernance of APIs
- historyHistory of APIs
- account_balancePolitics of APIs
Toolbox
- domainProviders
- apiAPIs
- cloudSolutions
- buildTools
- verifiedStandards
- gavelRegulations
- horizontal_ruleHeaders
- layersOverlays
- extensionExtensions
- schemaSchema
- policyPolicies
- ruleRules